Pharmacist Perspective: OC
Our Experiences With the Latest Treatment Options in Ovarian Cancer: The Pharmacist Perspective

Released: June 28, 2023

Sarah Hayward
Sarah Hayward, PharmD, BCOP
Amy Indorf
Amy Indorf, PharmD, BCOP

Activity

Progress
1
Course Completed

In this episode, Sarah Hayward, PharmD, BCOP, and Amy Ly Indorf, PharmD, BCOP, discuss their experiences providing care for patients with advanced ovarian cancer, with topics including:

  • PARP inhibitors as frontline maintenance therapy
  • Patient education and counseling on PARP inhibitors
  • Helping patients access newer therapies
  • Experiences with mirvetuximab soravtansine
  • Patient education and counseling on mirvetuximab soravtansine
  • Treatment modalities on the horizon